| |
| |
|
| Insider
Information: |
Lindahl Richard S |
| Relationship: |
EVP, Chief Financial O... |
| City: |
Reston |
| State: |
VA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
158,742 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$346,058 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
158,742 |
|
|
| Total
Value |
$346,058 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
1
|
|
Stock
price went up :
|
1
|
1
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
 7.6%
|
2.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
CEB Inc |
CEB |
Chief Financial Officer |
2017-04-05 |
0 |
2010-07-12 |
0 |
Premium* |
|
|
Emergent Biosolutions Inc. |
EBS |
EVP, Chief Financial O... |
2024-03-01 |
158,742 |
2018-05-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EBS |
Emergent Biosolutions Inc... |
EVP, Chief Financial Officer |
• – – |
2024-03-01 |
4 |
D |
$3.39 |
$2,319 |
D/D |
(684) |
158,742 |
0 |
- |
|
| EBS |
Emergent Biosolutions Inc... |
EVP, Chief Financial Officer |
• – – |
2024-02-29 |
4 |
D |
$3.23 |
$29,190 |
D/D |
(9,037) |
159,426 |
0 |
- |
|
| EBS |
Emergent Biosolutions Inc... |
EVP, Chief Financial Officer |
• – – |
2024-02-23 |
4 |
D |
$2.74 |
$1,417 |
D/D |
(517) |
168,463 |
0 |
- |
|
| EBS |
Emergent Biosolutions Inc... |
EVP, Chief Financial Officer |
• – – |
2024-02-21 |
4 |
D |
$2.71 |
$10,873 |
D/D |
(4,012) |
168,980 |
0 |
- |
|
| EBS |
Emergent Biosolutions Inc... |
EVP, Chief Financial Officer |
• – – |
2023-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
73,847 |
172,992 |
0 |
- |
|
| EBS |
Emergent Biosolutions Inc... |
EVP, Chief Financial Officer |
• – – |
2023-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
18,462 |
99,145 |
0 |
- |
|
| EBS |
Emergent Biosolutions Inc... |
EVP, Chief Financial Officer |
• – – |
2023-02-28 |
4 |
D |
$12.38 |
$13,296 |
D/D |
(1,074) |
16,906 |
0 |
- |
|
| EBS |
Emergent Biosolutions Inc... |
EVP, Chief Financial Officer |
• – – |
2023-02-24 |
4 |
D |
$13.71 |
$13,395 |
D/D |
(977) |
17,980 |
0 |
- |
|
| EBS |
Emergent Biosolutions Inc... |
EVP, Chief Financial Officer |
• – – |
2023-02-23 |
4 |
D |
$14.30 |
$6,349 |
D/D |
(444) |
18,957 |
0 |
- |
|
| EBS |
Emergent Biosolutions Inc... |
EVP, Chief Financial Officer |
• – – |
2023-02-08 |
4 |
D |
$13.25 |
$31,747 |
D/D |
(2,396) |
19,401 |
0 |
- |
|
| EBS |
Emergent Biosolutions Inc... |
EVP, Chief Financial Officer |
• – – |
2023-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
101 |
21,797 |
0 |
- |
|
| EBS |
Emergent Biosolutions Inc... |
EVP, Chief Financial Officer |
• – – |
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
48,333 |
86,291 |
0 |
- |
|
| EBS |
Emergent Biosolutions Inc... |
EVP, Chief Financial Officer |
• – – |
2022-02-28 |
4 |
D |
$39.64 |
$32,426 |
D/D |
(818) |
85,473 |
0 |
- |
|
| EBS |
Emergent Biosolutions Inc... |
EVP, Chief Financial Officer |
• – – |
2022-02-24 |
4 |
D |
$42.47 |
$41,748 |
D/D |
(983) |
37,958 |
0 |
- |
|
| EBS |
Emergent Biosolutions Inc... |
EVP, Chief Financial Officer |
• – – |
2022-02-23 |
4 |
D |
$42.23 |
$21,791 |
D/D |
(516) |
38,941 |
0 |
- |
|
| EBS |
Emergent Biosolutions Inc... |
EVP, Chief Financial Officer |
• – – |
2022-02-22 |
4 |
D |
$42.23 |
$97,045 |
D/D |
(2,298) |
39,457 |
0 |
- |
|
| EBS |
Emergent Biosolutions Inc... |
EVP, Chief Financial Officer |
• – – |
2022-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
1,836 |
41,755 |
0 |
- |
|
| EBS |
Emergent Biosolutions Inc... |
EVP, Chief Financial Officer |
• – – |
2021-11-15 |
4 |
B |
$37.46 |
$112,380 |
D/D |
3,000 |
39,919 |
2.74 |
% |
|
| EBS |
Emergent Biosolutions Inc... |
EVP, Chief Financial Officer |
• – – |
2021-05-08 |
4 |
D |
$61.62 |
$64,947 |
D/D |
(1,054) |
36,919 |
0 |
- |
|
| EBS |
Emergent Biosolutions Inc... |
EVP, Chief Financial Officer |
• – – |
2021-02-26 |
4 |
D |
$97.15 |
$79,566 |
D/D |
(819) |
37,973 |
0 |
- |
|
| EBS |
Emergent Biosolutions Inc... |
EVP, Chief Financial Officer |
• – – |
2021-02-24 |
4 |
D |
$93.49 |
$94,425 |
D/D |
(1,010) |
38,792 |
0 |
- |
|
| EBS |
Emergent Biosolutions Inc... |
EVP, Chief Financial Officer |
• – – |
2021-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
8,023 |
39,802 |
0 |
- |
|
| EBS |
Emergent Biosolutions Inc... |
EVP, Chief Financial Officer |
• – – |
2021-02-09 |
4 |
D |
$123.45 |
$311,341 |
D/D |
(2,522) |
31,779 |
0 |
- |
|
| EBS |
Emergent Biosolutions Inc... |
EVP, Chief Financial Officer |
• – – |
2021-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
2,495 |
34,301 |
0 |
- |
|
| EBS |
Emergent Biosolutions Inc... |
EVP, Chief Financial Officer |
• – – |
2020-05-08 |
4 |
D |
$79.25 |
$57,694 |
D/D |
(728) |
31,806 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
